Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1972 Apr;5(4):627–629. doi: 10.1128/iai.5.4.627-629.1972

Serum and Nasal Secretion Immune Response in Meningococcal Disease

Richard P Wenzel 1, John R Mitzel 1, John A Davies 1, Walter E Beam Jr 1
PMCID: PMC422415  PMID: 4629128

Abstract

Nasal antibodies to meningococcal organisms were demonstrable by the indirect fluorescent-antibody test in three patients. Serogroup cross-reactions were usual.

Full text

PDF
629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  2. Beam W. E., Jr, Newberg N. R., Devine L. F., Pierce W. E., Davies J. A. The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis. 1971 Jul;124(1):39–46. doi: 10.1093/infdis/124.1.39. [DOI] [PubMed] [Google Scholar]
  3. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969 Jun 1;129(6):1327–1348. doi: 10.1084/jem.129.6.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969 Jun 1;129(6):1367–1384. doi: 10.1084/jem.129.6.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gotschlich E. C., Liu T. Y., Artenstein M. S. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med. 1969 Jun 1;129(6):1349–1365. doi: 10.1084/jem.129.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Roberts R. B. The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med. 1970 Mar 1;131(3):499–513. doi: 10.1084/jem.131.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sanders E., Deal W. B. Prevention of meningococcal infections. J Infect Dis. 1970 Apr;121(4):449–451. doi: 10.1093/infdis/121.4.449. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES